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Cooperation in the cerebellum
 
y crossing knockout mice deficient for two cell adhesion 
molecules, Sakurai et al. have obtained the first genetic 
evidence for the molecules’ functional overlap, and have 
explained why earlier tissue culture results were not replicated 
in single knockout mice (page 1259).
Sakurai and colleagues started by engineering mice deficient 
 
for NrCAM, which had only mild (
 
 
 
11%) growth defects in two 
cerebellar lobes. When the authors crossed the NrCAM-deficient 
mice with existing mice that are deficient for the related cell 
adhesion molecule L1, the cerebellum of the double knockout 
was drastically reduced in size, and the mice were small and 
never survived later than eight days after birth. The mice probably 
die because their lack of coordination does not allow them to 
compete successfully for food.
The cerebellar defect may be largely a result of reduced 
migration or decreased survival of granule cells. In the double 
knockout, these interneurons initially differentiate and start 
migrating correctly, but they reach their final destination in vastly 
reduced numbers. There is no accumulation of these cells in 
other areas of the cerebellum, suggesting a survival problem.
The survival hypothesis would be consistent with tissue culture 
experiments, in which Sakurai et al. added L1 antibodies to 
cells isolated from NrCAM-deficient mice, and observed a 
dramatic reduction in viability at around day 14 of culture. 
More experiments along these lines should reveal the specific 
 
functions of L1, NrCAM, and the two other related CAMs 
(neurofascin and CHL1) in processes such as cell migration, 
axon bundling, and synaptogenesis. 
 
 
Mice lacking two adhesion molecules (right) have smaller cerebellums.
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Joined at the Hip
 
direct link between clathrin cages and actin is described 
on page 1209 by Engqvist-Goldstein et al.
The protein that forms the link is huntingtin interacting 
protein 1 related (Hip1R), which was characterized 
previously as an actin-binding protein that associates with 
clathrin-coated pits and vesicles. The related protein Hip1 
has been implicated in Huntington’s disease, where loss of an 
A
 
interaction between 
normal huntingtin 
protein and Hip1 
may cause problems 
with membrane– 
cytoskeletal integrity 
 
in the brain.
 
Engqvist-Goldstein 
 
et al. now show that 
Hip1R tightly asso-
ciates with clathrin 
during endocytosis  Hip1R (gold) bridges actin and clathrin.
 
and that purified Hip1R both binds to purified clathrin 
cages and stimulates cage assembly in vitro. They also show 
that clathrin cages assembled in vitro with Hip1R copellet 
with F-actin at low speed.
Other workers have induced the formation of clathrin 
coated pits using only clathrin, two coat proteins, and 
membranes. Actin and Hip1R may be needed, however, 
for the pits to mature into vesicles. The importance of the 
actin interaction can now be tested in cell culture systems. 
 
 
 
Sticky utrophin messages
 
n page 1173, Gramolini et al. report 
that utrophin mRNA is immobilized 
by binding to an actin-dependent structure. 
Manipulation of this system may be 
important for the therapy of Duchenne 
muscular dystrophy (DMD).
 
DMD is characterized by a weakened 
linkage from muscle cells to the extracellular 
matrix because of a compromised 
dystrophin complex. Utrophin may be 
able to substitute for dystrophin, but 
utrophin’s expression is normally limited 
to the areas near where nerves contact 
muscle cells. This is due, at least in part, 
to the concentration of utrophin mRNA 
to these regions.
In multinucleated muscle cells, the 
utrophin gene is preferentially expressed 
O
 
from nuclei that are close to the sites of 
nerve contact. Gramolini et al. now find 
that this high localized concentration 
of mRNA is then maintained by the 
binding of utrophin polysomes, via the 
 
utrophin 3
 
 
 
 untranslated region, to 
actin-dependent structures.
The possible relevance of these results to 
DMD therapy arises because individuals 
with DMD may mount an immune 
response to dystrophin introduced by 
gene therapy, given that the individual’s 
body has never seen the protein before. 
Although increased expression of utrophin 
should not cause such an autoimmune 
reaction, the localization of utrophin 
 
translation may limit utrophin’s usefulness. 
If, however, the tethering system 
described by Gramolini et al. can be 
manipulated with small molecules, the 
dispersed expression of utrophin may 
act as one element of a DMD therapy. 
 
  Utrophin mRNAs bind to actin.